mannitol has been researched along with Carcinoma, Small Cell in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Jager, R; Klastersky, J; Longeval, E | 1 |
Barnett, PA; Hellström, I; Hellström, KE; McCormick, CI; Neuwelt, EA; Ramsey, FL | 1 |
Fiamengo, SA; Kroll, RA; Muldoon, LL; Neuwelt, EA; Pagel, MA; Roman-Goldstein, S | 1 |
3 other study(ies) available for mannitol and Carcinoma, Small Cell
Article | Year |
---|---|
High-dose cisplatin with fluid and mannitol-induced diuresis in advanced lung cancer: a phase II clinical trial of the EORTC Lung Cancer Working Party (Belgium).
Topics: Adenocarcinoma; Adult; Aged; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Cisplatin; Diuresis; Drug Evaluation; Female; Humans; Lung Neoplasms; Male; Mannitol; Middle Aged; Nausea; Prognosis; Thrombocytopenia; Vomiting | 1980 |
Dexamethasone decreases the delivery of tumor-specific monoclonal antibody to both intracerebral and subcutaneous tumor xenografts.
Topics: Animals; Antibodies, Monoclonal; Antibody Specificity; Blood-Brain Barrier; Brain Neoplasms; Capillary Permeability; Carcinoma, Small Cell; Cell Line; Cell Survival; Dexamethasone; Humans; Mannitol; Neoplasm Transplantation; Rats; Rats, Nude | 1993 |
Improving drug delivery to intracerebral tumor and surrounding brain in a rodent model: a comparison of osmotic versus bradykinin modification of the blood-brain and/or blood-tumor barriers.
Topics: Animals; Blood-Brain Barrier; Bradykinin; Brain; Brain Neoplasms; Carcinoma, Small Cell; Female; Humans; Hypertonic Solutions; Lung Neoplasms; Mannitol; Neoplasm Transplantation; Rats; Rats, Nude; Tumor Cells, Cultured | 1998 |